Immunomedics (IMMU) EV/EBITDA US GAAP (year values) |
|||||||||
2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | -10.2 | -5.25 | -6.66 | -13.0 | -11.7 | -73.5 | ||
Changes by years, y/y, % | +33% | -49% | +27% | +95% | -10% | +8.8% |
Immunomedics. EV/EBITDA
Immunomedics. EV/EBITDA, changes, %
Immunomedics (IMMU) EV/EBITDA US GAAP (quarter values) |
||||||||
2019Q4 | 2020Q3 | 2020Q1 | 2020Q4 | 2020Q2 | LTM ? | |||
EV/EBITDA | ? | -12.1 | -7.82 | -7.82 | -28.0 | -28.0 | -73.5 | |
Changes by years, y/y, % | +2% | -2% | +132% | +227% | ||||
Changes by quarters, q/q, % | +57% | -35% | 0% | +259% | 0% |